- Home
- DNTH vs BMBL Comparison
DNTH vs BMBL Comparison
Compare DNTH & BMBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNTH
- BMBL
- Stock Information
- Founded
- DNTH 2015
- BMBL 2014
- Country
- DNTH United States
- BMBL United States
- Employees
- DNTH N/A
- BMBL N/A
- Industry
- DNTH Biotechnology: Pharmaceutical Preparations
- BMBL Computer Software: Prepackaged Software
- Sector
- DNTH Health Care
- BMBL Technology
- Exchange
- DNTH Nasdaq
- BMBL Nasdaq
- Market Cap
- DNTH 724.8M
- BMBL 828.7M
- IPO Year
- DNTH N/A
- BMBL 2021
- Fundamental
- Price
- DNTH $18.14
- BMBL $4.34
- Analyst Decision
- DNTH Strong Buy
- BMBL Hold
- Analyst Count
- DNTH 8
- BMBL 17
- Target Price
- DNTH $54.33
- BMBL $7.56
- AVG Volume (30 Days)
- DNTH 362.0K
- BMBL 3.6M
- Earning Date
- DNTH 03-11-2025
- BMBL 05-07-2025
- Dividend Yield
- DNTH N/A
- BMBL N/A
- EPS Growth
- DNTH N/A
- BMBL N/A
- EPS
- DNTH N/A
- BMBL N/A
- Revenue
- DNTH $6,235,000.00
- BMBL $1,071,643,000.00
- Revenue This Year
- DNTH N/A
- BMBL N/A
- Revenue Next Year
- DNTH N/A
- BMBL $0.20
- P/E Ratio
- DNTH N/A
- BMBL N/A
- Revenue Growth
- DNTH 120.63
- BMBL 1.88
- 52 Week Low
- DNTH $17.50
- BMBL $4.19
- 52 Week High
- DNTH $32.27
- BMBL $12.49
- Technical
- Relative Strength Index (RSI)
- DNTH 36.91
- BMBL 32.28
- Support Level
- DNTH $17.50
- BMBL $4.46
- Resistance Level
- DNTH $20.45
- BMBL $4.88
- Average True Range (ATR)
- DNTH 1.67
- BMBL 0.22
- MACD
- DNTH -0.22
- BMBL 0.06
- Stochastic Oscillator
- DNTH 10.44
- BMBL 17.24
About DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.
About BMBL Bumble Inc.
Bumble Inc is engaged in offering online dating services. The company operates two apps, Bumble and Badoo, where users come every month to discover new people and connect.